ARTV insider transaction filings
Artiva Biotherapeutics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-15. Screen ARTV transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 34 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 13 legs across 7 filings by 6 insiders — 573,079 shares, $5,428,409 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 7 filings by 4 insiders — 113,825 shares, $1,271,536 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
- Largest priced transaction: purchase of 152,472 shares @ $8.93 ($1,361,575) by RA CAPITAL MANAGEMENT, L.P., filed 2026-07-20.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner & RA Capital Healthcare Fund LP — Director, 10% owner & RA Capital Nexus Fund, L.P. — Director & RA Capital Nexus Fund III, L.P. — Director & Kolchinsky Peter — Director, 10% owner & Shah Rajeev M. — Director, 10% owner | 9 | 13 legs · 573,079 sh · $5,428,409 | — | 2 |
| Aslan Fred — Chief Executive Officer, Director | 4 | — | 2 legs · 85,317 sh · $946,138 | 4 |
| Banerjee Subhashis — Chief Medical Officer | 4 | — | 3 legs · 9,751 sh · $116,155 | 6 |
| Horan Christopher — Chief Tech Operations Officer | 2 | — | 1 leg · 10,366 sh · $115,638 | 2 |
| Bush Jennifer — COO, CLO, Compliance Officer | 2 | — | 1 leg · 8,391 sh · $93,606 | 2 |
| Baker Daniel G. — Director | 2 | — | — | 2 |
| DANIELS BRIAN — Director | 2 | — | — | 2 |
| HOUGEN ELIZABETH L — Director | 2 | — | — | 2 |
| MOORE ALISON — Director | 2 | — | — | 2 |
| Miralles Gines Diego — President & Head of R&D | 1 | — | — | 2 |
+2 more insiders in the window, not shown — every filing appears in the table below.
Recent Form 4 filings — Artiva Biotherapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | Aslan Fred — Chief Executive Officer, Director | Grant/award (A): 110,000 @ $0 · Grant/award (A): 315,000 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | Aslan Fred — Chief Executive Officer, Director | Grant/award (A): 45,000 @ $0 · Grant/award (A): 155,000 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | MOORE ALISON — Director | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | Baker Daniel G. — Director | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | DANIELS BRIAN — Director | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | HOUGEN ELIZABETH L — Director | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | Sorg Elaine K. — Director | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | Stoppel Laura — Director | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-11 | 4 | Miralles Gines Diego — President & Head of R&D | Grant/award (A): 45,000 @ $0 · Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2026-09-11 | 4 | Banerjee Subhashis — Chief Medical Officer | Grant/award (A): 30,000 @ $0 · Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2026-09-11 | 4 | Bush Jennifer — COO, CLO, Compliance Officer | Grant/award (A): 45,000 @ $0 · Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2026-09-11 | 4 | Horan Christopher — Chief Tech Operations Officer | Grant/award (A): 40,000 @ $0 · Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2026-09-09 | 4 | Aslan Fred — Chief Executive Officer, Director | Sale (S): 23,429 @ $10.92 | EDGAR |
| 2026-09-08 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | Stoppel Laura — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | Baker Daniel G. — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | DANIELS BRIAN — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | HOUGEN ELIZABETH L — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | Sorg Elaine K. — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | MOORE ALISON — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-04 | 4 | Aslan Fred — Chief Executive Officer, Director | Sale (S): 61,888 @ $11.16 | EDGAR |
| 2026-09-04 | 4 | Banerjee Subhashis — Chief Medical Officer | Sale (S): 1,100 @ $11.16 | EDGAR |
| 2026-09-04 | 4 | Bush Jennifer — COO, CLO, Compliance Officer | Sale (S): 8,391 @ $11.16 | EDGAR |
| 2026-09-04 | 4 | Horan Christopher — Chief Tech Operations Officer | Sale (S): 10,366 @ $11.16 | EDGAR |
| 2026-08-31 | 4 | Banerjee Subhashis — Chief Medical Officer | Option exercise (M): 5,306 @ $1.92 · Sale (S): 8,222 @ $12.01 · Option exercise (M): 5,306 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Banerjee Subhashis — Chief Medical Officer | Option exercise (M): 429 @ $1.92 · Sale (S): 429 @ $12 · Option exercise (M): 429 (derivative) @ $0 | EDGAR |
| 2026-07-31 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 20,824 @ $9.99 · Purchase (P): 24,944 @ $9.93 | EDGAR |
| 2026-07-28 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 41,319 @ $9.99 | EDGAR |
| 2026-07-23 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 120,582 @ $9.55 · Purchase (P): 84,124 @ $9.93 · Purchase (P): 59,880 @ $9.96 | EDGAR |
| 2026-07-23 | 4/A | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 6,522 @ $8.94 | EDGAR |
| 2026-07-20 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 152,472 @ $8.93 · Purchase (P): 7,882 @ $8.95 | EDGAR |
| 2026-07-14 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 15,102 @ $8.97 · Purchase (P): 6,552 @ $8.94 | EDGAR |
| 2026-06-29 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 31,000 @ $8.88 · Purchase (P): 1,876 @ $8.98 | EDGAR |
| 2026-06-16 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 391,019 @ $8.57 · Purchase (P): 15,414 @ $8.99 · Purchase (P): 124,893 @ $8.89 | EDGAR |
| 2026-06-11 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 479,039 @ $6.91 · Purchase (P): 103 @ $7 · Purchase (P): 548,580 @ $7.91 | EDGAR |
| 2026-05-28 | 4 | GC Corp. — 10% owner GC Cell Corp — 10% owner | Purchase (P): 1,085,069 @ $11.52 · Purchase (P): 347,222 @ $11.52 | EDGAR |
| 2026-05-19 | 4 | Raymon Heather — SVP, Research and Development | Sale (S): 3,095 @ $9.01 | EDGAR |
| 2026-05-19 | 4 | Banerjee Subhashis — Chief Medical Officer | Sale (S): 7,037 @ $9.01 | EDGAR |
| 2026-05-19 | 4 | Aslan Fred — Chief Executive Officer, Director | Sale (S): 27,116 @ $9.01 | EDGAR |
| 2026-05-19 | 4 | Miralles Gines Diego — President & Head of R&D | Grant/award (A): 77,500 @ $0 · Grant/award (A): 232,500 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Horan Christopher — Chief Tech Operations Officer | Sale (S): 7,002 @ $9.01 | EDGAR |
| 2026-05-19 | 4 | Bush Jennifer — COO, CLO, Compliance Officer | Sale (S): 8,790 @ $9.01 | EDGAR |
| 2026-05-13 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 6,510,416 @ $11.52 · Purchase (P): 2,170,138 (derivative) @ $11.52 | EDGAR |
| 2026-03-10 | 4 | Huston Thad Allen — Chief Financial Officer | Grant/award (A): 220,000 @ $0 | EDGAR |
| 2026-02-19 | 4 | Sorg Elaine K. — Director | Grant/award (A): 27,500 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Banerjee Subhashis — Chief Medical Officer | Grant/award (A): 102,000 @ $0 | EDGAR |
| 2026-02-18 | 4 | Aslan Fred — President and CEO, Director | Grant/award (A): 366,850 @ $0 · Tax withholding (F): 14,600 @ $4 | EDGAR |
| 2026-02-18 | 4 | Horan Christopher — Chief Tech Operations Officer | Grant/award (A): 117,300 @ $0 · Tax withholding (F): 2,187 @ $4 | EDGAR |
| 2026-02-18 | 4 | Bush Jennifer — COO, CLO, Secy, Compliance Off | Grant/award (A): 117,300 @ $0 · Tax withholding (F): 3,515 @ $4 | EDGAR |
Recent 8-K events — Artiva Biotherapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-12-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ARTV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →